The potential of genetics
         to enable personalization of healthcare

                      Professor Ian N M Day
                     MRC Centre (CAiTE) and
             Bristol Genetic Epidemiology Laboratory
                  Department of Social Medicine
                  Oakfield House, Oakfield Grove
                        University of Bristol

Bristol Enterprise Network event „The Personalised Healthcare Revolution‟
8th October 2009
Bristol Zoo
What is in your genome?
• 3000 million A,C,G,T bases strung together into 23 long
  molecules (chromosomes)
• The base sequence is your blueprint
• There are about 20,000 ‘genes’
• Each gene encodes a protein, e.g.haemoglobin
• 99% does NOT encode proteins. ?junk
• About 1% of bases are ‘polymorphic’
• You may have about 1m more ‘private’ variations
• Mutation of one base may cause a major disease
• You are 96% the same as chimp, 99.5% in protein coding
Where is your genome?
• There is a copy in every cell of your body
• Different genes are active in different cells
• However, you only copy half your genome
  into a sperm or an egg
Does the hypercholesterolaemia run
 in the family with the LDLR gene?
Melt-MADGE
                                                Loading the gel
Pouring one gel        Pouring 16 gels




Melt-MADGE system

                          Melt-MADGE tank
                                            Glass-gel-glass sandwich
“ScanLab”
   (same system to run melts and endoVII assays)




   >>Goal – studying unknown mutations in populations … studies in
                    big case collections also feasible
>>Present capacity – 10 systems – 50million base pairs scanned per week
Found 1 severe mutation in MC4R
   in 1,100 population sample
                        •   Khalid K. Alharbi1, Emmanuel Spanakis1,
                            Karen Tan2, Matt J. Smith1, Mohammed
                            A. Aldahmesh1, Sandra D. O'Dell1, Avan
                            Aihie Sayer3, Debbie A. Lawlor4, Shah
                            Ebrahim5, George Davey Smith4,
                            Stephen O’Rahilly3, Sadaf Farooqi2 ,
                            Cyrus Cooper3, David I.W.Phillips3 and
                            Ian N M Day1
                            Prevalence and functionality
                            of paucimorphic and private
                            MC4R mutations in a large,
                            unselected European British
                            population, scanned by
                            meltMADGE (Human
                            Mutation 2006) (cat.P114)

         MC4R A87D > (Appetite++) > BMI 31.5kg/m2
          Does everybody have “one worst gene”?
          Can we help them (cf phenylketonuria)?
From RV-CD to CV-CD
• Rare variant – common disease

• Common variant – common disease
BMI GWAS - SNPs near MC4R
BMI GWAS - SNPs near MC4R
Forest Plot / Meta-Analysis of Cohorts
        MC4R lead SNP in replication studies




     Common variants near MC4R are associated with fat mass, weight and risk of
                                    obesity.
Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, Berndt SI; Prostate, Lung, Colorectal, and Ovarian
  (PLCO) Cancer Screening Trial, Jacobs KB, Chanock SJ, Hayes RB, Bergmann S, Bennett AJ, Bingham SA, Bochud M, Brown M, Cauchi S, Connell JM, Cooper C,
 Smith GD, Day I, Dina C, De S, Dermitzakis ET, Doney AS, Elliott KS, Elliott P, Evans DM, Sadaf Farooqi I, Froguel P, Ghori J, Groves CJ, Gwilliam R, Hadley D, Hall
AS, Hattersley AT, Hebebrand J, Heid IM; KORA, Lamina C, Gieger C, Illig T, Meitinger T, Wichmann HE, Herrera B, Hinney A, Hunt SE, Jarvelin MR, Johnson T, Jolley
JD, Karpe F, Keniry A, Khaw KT, Luben RN, Mangino M, Marchini J, McArdle WL, McGinnis R, Meyre D, Munroe PB, Morris AD, Ness AR, Neville MJ, Nica AC, Ong KK,
 O'Rahilly S, Owen KR, Palmer CN, Papadakis K, Potter S, Pouta A, Qi L; Nurses' Health Study, Randall JC, Rayner NW, Ring SM, Sandhu MS, Scherag A, Sims MA,
   Song K, Soranzo N, Speliotes EK; Diabetes Genetics Initiative, Syddall HE, Teichmann SA, Timpson NJ, Tobias JH, Uda M; SardiNIA Study, Vogel CI, Wallace C,
Waterworth DM, Weedon MN; Wellcome Trust Case Control Consortium, Willer CJ; FUSION, Wraight, Yuan X, Zeggini E, Hirschhorn JN, Strachan DP, Ouwehand WH,
 Caulfield MJ, Samani NJ, Frayling TM, Vollenweider P, Waeber G, Mooser V, Deloukas P, McCarthy MI, Wareham NJ, Barroso I, Jacobs KB, Chanock SJ, Hayes RB,
 Lamina C, Gieger C, Illig T, Meitinger T, Wichmann HE, Kraft P, Hankinson SE, Hunter DJ, Hu FB, Lyon HN, Voight BF, Ridderstrale M, Groop L, Scheet P, Sanna S,
                          Abecasis GR, Albai G, Nagaraja R, Schlessinger D, Jackson AU, Tuomilehto J, Collins FS, Boehnke M, Mohlke KL.
                                                        Nat Genet. 2008 Jun;40(6):768-75. Epub 2008 May 4.
Effect size of SNP locus near MC4R
Slide deleted
Slide deleted
Slide deleted
Helicopter view of genome+diseases:
          cGWAS browser
What Sells to the Public?
•   Judged by Internet traffic
•   1. Internet (indexing by web crawlers)
•   2. Sex
•   3. Genealogy
Slide deleted
Slide deleted
Slide deleted
Slide deleted
What Sells to the Doctors?
•   Genetic information that will help clinical process
•   1. diagnosis
•   2. prognosis
•   3. monitoring
•   4. screening
•   5. Non-directive counselling /reproductive choice

• 6. !! Not the patient’s right to know
Some real clinical examples
      (single targetted gene tests)
• TPMT / thiopurines azathioprine, 6-mercaptopurine and 6-
  thioguanine / organ Tx / autoimmune disease/ leukaemias
• Her2/NEU / breast cancer drug response
• VKORC1/CYP2C9 / warfarin dosing
• UGT1A1 /Gilbert’s / irinotecan / colon cancer
• DPYD, TS / 5-fluorouracil / gastric cancer

• (ABO) – blood group 1900-1925
Who gets the statins?




 Average prescribing cutpoint

 Red genotype over-represented and blue genotype under-represented relative
to black genotype. If we know the curves, then we could just use the genotype
ratios in those getting the statin, to determine the average prescribing cutpoint

      Genotype ratio treatment index (GRTI)
        NHS research of service delivery?
What does it all cost (2009)?
• 600,000 common polymorphisms (GWAS)
• £300 from 23andMe [NB £40 200K panels imminent]

• ‘Complete’ genome sequencing (NGS)
• £50,000
• 5 year goal of 1,000 dollar genome

• The cost of making sense of it all.
• The cost of leveraging value (to whoever) of that meaning
Urban(e) Dog Tags? (slide modified)
• identity
• blood type and history of inoculations

•   Blood group
•   Statin myopathy risk
•   CFTR delta508, HBB E6V
•   ALDH2 status
•   BCHE D70G
•   LCT
•   Norwalk virus resistance
•   MC1R, OCA2

• What I would really like for Xmas is
  my complete genome sequence!
Ian Day Edited Presentation

More Related Content

PPTX
DNA Methylation in Young Women Breast Cancer
PPT
24 janvier CROQUER LA VIE - Dr Thomas Seyfried
PPTX
Gtc presentation 2
PPTX
Human genetic diversity and origin of major human groups
PPTX
Cancer prevention and treatment
PDF
Bioinformatics & biostatistics tools for monogenic and multifactorial disease...
PDF
Genome wide study
PDF
CV, 2007 update LinkedIn
DNA Methylation in Young Women Breast Cancer
24 janvier CROQUER LA VIE - Dr Thomas Seyfried
Gtc presentation 2
Human genetic diversity and origin of major human groups
Cancer prevention and treatment
Bioinformatics & biostatistics tools for monogenic and multifactorial disease...
Genome wide study
CV, 2007 update LinkedIn

What's hot (19)

PPTX
TriStar CSC
PPTX
Ovarian_Cancer_Presentation-Tritz_VanLith_WareJoncas_Elwell
PDF
Bibliography: Cancer Ver 1.2
PDF
Vitamin D and Ovarian Cancer_Crimson publishers
PDF
Genome Wide SNP Analysis for Inferring the Population Structure and Genetic H...
PDF
Publications
PPT
DNA repair and prostate cancer
DOCX
Dissertation Final Draft
PDF
Transcriptome Analysis of Spontaneous PDF
PPT
Update in oncology
PPTX
Expanding treatment platform in m crc bayer - asyut 2018
PPTX
Biochemical and cellular implications of drug resistant malaria
PDF
Ong et al_The M694V mutation in Armenian-Americans_a 10-year retrospective st...
PDF
A link between premenopausal iron deficiency and breast cancer malignancy
PDF
Mapping genomic regions associated with Maize Lethal Necrosis (MLN) using QTL...
PPTX
Msd msi high solid tumors
PDF
Gene expression analysis of a Helicobacter pyloriinfected and high-salt diet-...
PDF
Rectal cancer 2
PPTX
Bill Faloon on Anti-Aging Drugs at DaVinci 50 Conference, 2021
TriStar CSC
Ovarian_Cancer_Presentation-Tritz_VanLith_WareJoncas_Elwell
Bibliography: Cancer Ver 1.2
Vitamin D and Ovarian Cancer_Crimson publishers
Genome Wide SNP Analysis for Inferring the Population Structure and Genetic H...
Publications
DNA repair and prostate cancer
Dissertation Final Draft
Transcriptome Analysis of Spontaneous PDF
Update in oncology
Expanding treatment platform in m crc bayer - asyut 2018
Biochemical and cellular implications of drug resistant malaria
Ong et al_The M694V mutation in Armenian-Americans_a 10-year retrospective st...
A link between premenopausal iron deficiency and breast cancer malignancy
Mapping genomic regions associated with Maize Lethal Necrosis (MLN) using QTL...
Msd msi high solid tumors
Gene expression analysis of a Helicobacter pyloriinfected and high-salt diet-...
Rectal cancer 2
Bill Faloon on Anti-Aging Drugs at DaVinci 50 Conference, 2021
Ad

Similar to Ian Day Edited Presentation (20)

PPTX
Cancer Biology.pptx
PDF
Cancer Biology For a Surgeon to understand
PPTX
Bea lehming memorial lectures cacs - washington dc 11-15-2014
PPT
cancer.ppt
PPTX
2013 03 genomic medicine slides
PDF
#HCAQofQ Tariq Mughal
PDF
Question of Quality Conference 2016 - Personalized Cancer Medicine
PDF
2013 05 society for clinical trials
PDF
2014 07 ismb personalized medicine
PPTX
CancerBioinformatics_DataTypesResources_012215.pptx
PPTX
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
PPTX
cancer nursing: definition till management.pptx
PDF
Andres Metspalu: The Estonian Genome Project
 
PDF
Stem cell therapies - a special case of therapy and research
PPTX
Ana Ramírez de Molina-El impacto de las ciencias ómicas en la medicina, la nu...
PPTX
Ana Ramírez de Molina-El impacto de las ciencias ómicas en la medicina, la nu...
PPTX
Cancer lecture
PPT
human induced pluripotent stem cells in cancer treatment
PPTX
TEGENE ALEMU CANCER BIOLOGY SURGERY DEPARTMENT
Cancer Biology.pptx
Cancer Biology For a Surgeon to understand
Bea lehming memorial lectures cacs - washington dc 11-15-2014
cancer.ppt
2013 03 genomic medicine slides
#HCAQofQ Tariq Mughal
Question of Quality Conference 2016 - Personalized Cancer Medicine
2013 05 society for clinical trials
2014 07 ismb personalized medicine
CancerBioinformatics_DataTypesResources_012215.pptx
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
cancer nursing: definition till management.pptx
Andres Metspalu: The Estonian Genome Project
 
Stem cell therapies - a special case of therapy and research
Ana Ramírez de Molina-El impacto de las ciencias ómicas en la medicina, la nu...
Ana Ramírez de Molina-El impacto de las ciencias ómicas en la medicina, la nu...
Cancer lecture
human induced pluripotent stem cells in cancer treatment
TEGENE ALEMU CANCER BIOLOGY SURGERY DEPARTMENT
Ad

More from Bath & Bristol Enterprise Network (20)

PPT
Ray mc connell competitive strategy
PPTX
Matthew howell the role of ip in competitive strategy
PPT
Martin coulthard - keeping an edge - sustainable competitive advantage
PDF
Vanessa Moon Presentation
PPTX
Nick Sturge - Presentation
PPTX
Financial modelling presentation - M Dawes
PDF
G Commins - Sales & marketing
PPTX
Roadmaps a personal view
PPTX
Huw Davies - Sales & Marketing
PPT
Core 1 From Idea To Plan - Chris Tanner
PPT
Core 1 from idea to plan - Tim Monks
PPT
Core 1 from idea to plan - Mark Farmer
PPT
Martin coulthard intro - sales chasm
PPTX
Presentation n hopkins
PPTX
Presentation d sykes
PPTX
Presentation d gilroy
DOCX
Presentation notes t forster
PPTX
Trevor Forster Presentation - Profit from Design
Ray mc connell competitive strategy
Matthew howell the role of ip in competitive strategy
Martin coulthard - keeping an edge - sustainable competitive advantage
Vanessa Moon Presentation
Nick Sturge - Presentation
Financial modelling presentation - M Dawes
G Commins - Sales & marketing
Roadmaps a personal view
Huw Davies - Sales & Marketing
Core 1 From Idea To Plan - Chris Tanner
Core 1 from idea to plan - Tim Monks
Core 1 from idea to plan - Mark Farmer
Martin coulthard intro - sales chasm
Presentation n hopkins
Presentation d sykes
Presentation d gilroy
Presentation notes t forster
Trevor Forster Presentation - Profit from Design

Recently uploaded (20)

PDF
Developing a website for English-speaking practice to English as a foreign la...
PDF
Taming the Chaos: How to Turn Unstructured Data into Decisions
PDF
The influence of sentiment analysis in enhancing early warning system model f...
PDF
sustainability-14-14877-v2.pddhzftheheeeee
PPT
Geologic Time for studying geology for geologist
PDF
OpenACC and Open Hackathons Monthly Highlights July 2025
PDF
Consumable AI The What, Why & How for Small Teams.pdf
PDF
Architecture types and enterprise applications.pdf
PDF
Hybrid horned lizard optimization algorithm-aquila optimizer for DC motor
PPTX
Custom Battery Pack Design Considerations for Performance and Safety
PDF
Abstractive summarization using multilingual text-to-text transfer transforme...
PPTX
AI IN MARKETING- PRESENTED BY ANWAR KABIR 1st June 2025.pptx
PDF
Five Habits of High-Impact Board Members
PPTX
Configure Apache Mutual Authentication
PDF
Convolutional neural network based encoder-decoder for efficient real-time ob...
PDF
CloudStack 4.21: First Look Webinar slides
PDF
UiPath Agentic Automation session 1: RPA to Agents
PDF
How ambidextrous entrepreneurial leaders react to the artificial intelligence...
PDF
A Late Bloomer's Guide to GenAI: Ethics, Bias, and Effective Prompting - Boha...
PPT
Module 1.ppt Iot fundamentals and Architecture
Developing a website for English-speaking practice to English as a foreign la...
Taming the Chaos: How to Turn Unstructured Data into Decisions
The influence of sentiment analysis in enhancing early warning system model f...
sustainability-14-14877-v2.pddhzftheheeeee
Geologic Time for studying geology for geologist
OpenACC and Open Hackathons Monthly Highlights July 2025
Consumable AI The What, Why & How for Small Teams.pdf
Architecture types and enterprise applications.pdf
Hybrid horned lizard optimization algorithm-aquila optimizer for DC motor
Custom Battery Pack Design Considerations for Performance and Safety
Abstractive summarization using multilingual text-to-text transfer transforme...
AI IN MARKETING- PRESENTED BY ANWAR KABIR 1st June 2025.pptx
Five Habits of High-Impact Board Members
Configure Apache Mutual Authentication
Convolutional neural network based encoder-decoder for efficient real-time ob...
CloudStack 4.21: First Look Webinar slides
UiPath Agentic Automation session 1: RPA to Agents
How ambidextrous entrepreneurial leaders react to the artificial intelligence...
A Late Bloomer's Guide to GenAI: Ethics, Bias, and Effective Prompting - Boha...
Module 1.ppt Iot fundamentals and Architecture

Ian Day Edited Presentation

  • 1. The potential of genetics to enable personalization of healthcare Professor Ian N M Day MRC Centre (CAiTE) and Bristol Genetic Epidemiology Laboratory Department of Social Medicine Oakfield House, Oakfield Grove University of Bristol Bristol Enterprise Network event „The Personalised Healthcare Revolution‟ 8th October 2009 Bristol Zoo
  • 2. What is in your genome? • 3000 million A,C,G,T bases strung together into 23 long molecules (chromosomes) • The base sequence is your blueprint • There are about 20,000 ‘genes’ • Each gene encodes a protein, e.g.haemoglobin • 99% does NOT encode proteins. ?junk • About 1% of bases are ‘polymorphic’ • You may have about 1m more ‘private’ variations • Mutation of one base may cause a major disease • You are 96% the same as chimp, 99.5% in protein coding
  • 3. Where is your genome? • There is a copy in every cell of your body • Different genes are active in different cells • However, you only copy half your genome into a sperm or an egg
  • 4. Does the hypercholesterolaemia run in the family with the LDLR gene?
  • 5. Melt-MADGE Loading the gel Pouring one gel Pouring 16 gels Melt-MADGE system Melt-MADGE tank Glass-gel-glass sandwich
  • 6. “ScanLab” (same system to run melts and endoVII assays) >>Goal – studying unknown mutations in populations … studies in big case collections also feasible >>Present capacity – 10 systems – 50million base pairs scanned per week
  • 7. Found 1 severe mutation in MC4R in 1,100 population sample • Khalid K. Alharbi1, Emmanuel Spanakis1, Karen Tan2, Matt J. Smith1, Mohammed A. Aldahmesh1, Sandra D. O'Dell1, Avan Aihie Sayer3, Debbie A. Lawlor4, Shah Ebrahim5, George Davey Smith4, Stephen O’Rahilly3, Sadaf Farooqi2 , Cyrus Cooper3, David I.W.Phillips3 and Ian N M Day1 Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE (Human Mutation 2006) (cat.P114) MC4R A87D > (Appetite++) > BMI 31.5kg/m2 Does everybody have “one worst gene”? Can we help them (cf phenylketonuria)?
  • 8. From RV-CD to CV-CD • Rare variant – common disease • Common variant – common disease
  • 9. BMI GWAS - SNPs near MC4R
  • 10. BMI GWAS - SNPs near MC4R
  • 11. Forest Plot / Meta-Analysis of Cohorts MC4R lead SNP in replication studies Common variants near MC4R are associated with fat mass, weight and risk of obesity. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, Inouye M, Freathy RM, Attwood AP, Beckmann JS, Berndt SI; Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, Jacobs KB, Chanock SJ, Hayes RB, Bergmann S, Bennett AJ, Bingham SA, Bochud M, Brown M, Cauchi S, Connell JM, Cooper C, Smith GD, Day I, Dina C, De S, Dermitzakis ET, Doney AS, Elliott KS, Elliott P, Evans DM, Sadaf Farooqi I, Froguel P, Ghori J, Groves CJ, Gwilliam R, Hadley D, Hall AS, Hattersley AT, Hebebrand J, Heid IM; KORA, Lamina C, Gieger C, Illig T, Meitinger T, Wichmann HE, Herrera B, Hinney A, Hunt SE, Jarvelin MR, Johnson T, Jolley JD, Karpe F, Keniry A, Khaw KT, Luben RN, Mangino M, Marchini J, McArdle WL, McGinnis R, Meyre D, Munroe PB, Morris AD, Ness AR, Neville MJ, Nica AC, Ong KK, O'Rahilly S, Owen KR, Palmer CN, Papadakis K, Potter S, Pouta A, Qi L; Nurses' Health Study, Randall JC, Rayner NW, Ring SM, Sandhu MS, Scherag A, Sims MA, Song K, Soranzo N, Speliotes EK; Diabetes Genetics Initiative, Syddall HE, Teichmann SA, Timpson NJ, Tobias JH, Uda M; SardiNIA Study, Vogel CI, Wallace C, Waterworth DM, Weedon MN; Wellcome Trust Case Control Consortium, Willer CJ; FUSION, Wraight, Yuan X, Zeggini E, Hirschhorn JN, Strachan DP, Ouwehand WH, Caulfield MJ, Samani NJ, Frayling TM, Vollenweider P, Waeber G, Mooser V, Deloukas P, McCarthy MI, Wareham NJ, Barroso I, Jacobs KB, Chanock SJ, Hayes RB, Lamina C, Gieger C, Illig T, Meitinger T, Wichmann HE, Kraft P, Hankinson SE, Hunter DJ, Hu FB, Lyon HN, Voight BF, Ridderstrale M, Groop L, Scheet P, Sanna S, Abecasis GR, Albai G, Nagaraja R, Schlessinger D, Jackson AU, Tuomilehto J, Collins FS, Boehnke M, Mohlke KL. Nat Genet. 2008 Jun;40(6):768-75. Epub 2008 May 4.
  • 12. Effect size of SNP locus near MC4R
  • 16. Helicopter view of genome+diseases: cGWAS browser
  • 17. What Sells to the Public? • Judged by Internet traffic • 1. Internet (indexing by web crawlers) • 2. Sex • 3. Genealogy
  • 22. What Sells to the Doctors? • Genetic information that will help clinical process • 1. diagnosis • 2. prognosis • 3. monitoring • 4. screening • 5. Non-directive counselling /reproductive choice • 6. !! Not the patient’s right to know
  • 23. Some real clinical examples (single targetted gene tests) • TPMT / thiopurines azathioprine, 6-mercaptopurine and 6- thioguanine / organ Tx / autoimmune disease/ leukaemias • Her2/NEU / breast cancer drug response • VKORC1/CYP2C9 / warfarin dosing • UGT1A1 /Gilbert’s / irinotecan / colon cancer • DPYD, TS / 5-fluorouracil / gastric cancer • (ABO) – blood group 1900-1925
  • 24. Who gets the statins? Average prescribing cutpoint Red genotype over-represented and blue genotype under-represented relative to black genotype. If we know the curves, then we could just use the genotype ratios in those getting the statin, to determine the average prescribing cutpoint Genotype ratio treatment index (GRTI) NHS research of service delivery?
  • 25. What does it all cost (2009)? • 600,000 common polymorphisms (GWAS) • £300 from 23andMe [NB £40 200K panels imminent] • ‘Complete’ genome sequencing (NGS) • £50,000 • 5 year goal of 1,000 dollar genome • The cost of making sense of it all. • The cost of leveraging value (to whoever) of that meaning
  • 26. Urban(e) Dog Tags? (slide modified) • identity • blood type and history of inoculations • Blood group • Statin myopathy risk • CFTR delta508, HBB E6V • ALDH2 status • BCHE D70G • LCT • Norwalk virus resistance • MC1R, OCA2 • What I would really like for Xmas is my complete genome sequence!